| dbo:abstract |
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. (en) |
| dbo:foundingYear |
1998-01-01 (xsd:gYear) |
| dbo:type |
dbr:Public_company |
| dbo:wikiPageExternalLink |
http://www.oncolyticsbiotech.com/ http://www.oncolyticsbiotech.com/for-investors/rss-feeds/default.aspx http://www.oncolyticsbiotech.com https://dl.dropboxusercontent.com/u/38536036/ONCY%20PFIC/ONCY_PFIC.pdf |
| dbo:wikiPageID |
28902690 (xsd:integer) |
| dbo:wikiPageLength |
20060 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1114886378 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Calgary dbr:Canada dbr:Carboplatin dbr:Natural_killer_cell dbr:Antigen-presenting_cell dbr:Pelareorep dbr:Pembrolizumab dbr:Cytokine dbr:Reoviridae dbr:Public_company dbr:Gemcitabine dbc:Pharmaceutical_companies_established_in_1998 dbr:Lenalidomide dbr:Pancreatic_cancer dbr:Passive_foreign_investment_company dbc:Companies_listed_on_the_Toronto_Stock_Exchange dbr:Alberta dbr:Northwestern_University dbr:Paclitaxel dbr:Fast_track_(FDA) dbr:Ras_subfamily dbc:Pharmaceutical_companies_of_Canada dbr:Chemokine dbr:Pomalidomide dbr:Merck_Group dbr:Calgary,_Alberta dbr:T_cell |
| dbp:foundation |
1998 (xsd:integer) |
| dbp:homepage |
http://www.oncolyticsbiotech.com |
| dbp:industry |
Biopharmaceutical (en) |
| dbp:keyPeople |
Matt Coffey Ph.D. - President, and Chief Executive Officer, Chief Operating Officer; Kirk Look, CA - Chief Financial Officer; Andres A. Gutierrez, M.D., Ph.D. - Chief Medical Officer; Andrew de Guttadauro, President, Oncolytics Biotech Inc. (en) |
| dbp:locationCity |
dbr:Calgary,_Alberta |
| dbp:locationCountry |
dbr:Canada |
| dbp:name |
Oncolytics Biotech Inc. (en) |
| dbp:products |
REOLYSIN, a first-in-class intravenously delivered immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. (en) |
| dbp:tradedAs |
, NASDAQ:ONCY (en) |
| dbp:type |
dbr:Public_company |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Infobox_company dbt:Reflist dbt:Update dbt:TSX |
| dcterms:subject |
dbc:Pharmaceutical_companies_established_in_1998 dbc:Companies_listed_on_the_Toronto_Stock_Exchange dbc:Pharmaceutical_companies_of_Canada |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesListedOnNASDAQ yago:WikicatCompaniesListedOnTheTorontoStockExchange yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesEstablishedIn1998 yago:WikicatPharmaceuticalCompaniesOfCanada |
| rdfs:comment |
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. (en) |
| rdfs:label |
Oncolytics Biotech (en) |
| owl:sameAs |
freebase:Oncolytics Biotech yago-res:Oncolytics Biotech wikidata:Oncolytics Biotech https://global.dbpedia.org/id/NN26 |
| skos:closeMatch |
http://www.grid.ac/institutes/grid.459870.7 |
| prov:wasDerivedFrom |
wikipedia-en:Oncolytics_Biotech?oldid=1114886378&ns=0 |
| foaf:homepage |
http://www.oncolyticsbiotech.com |
| foaf:isPrimaryTopicOf |
wikipedia-en:Oncolytics_Biotech |
| foaf:name |
Oncolytics Biotech Inc. (en) |
| is dbo:wikiPageRedirects of |
dbr:Oncolytics_Biotech_Inc. |
| is dbo:wikiPageWikiLink of |
dbr:Pelareorep dbr:Companies_listed_on_the_Toronto_Stock_Exchange_(O) dbr:Oncolytics_Biotech_Inc. |
| is foaf:primaryTopic of |
wikipedia-en:Oncolytics_Biotech |